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Rhodococcus equi: Conversion of a saprophyte
bacterium into an intracellular pathogen
R. Miranda-CasoLuengo*, A.A. Miranda-CasoLuengo, X.
Wang, W.G. Meijer
UCD School of Biomolecular and Biomedical Science, University
College, Dublin, Ireland
Rhodococcus equi is a primary pathogen of the lower respiratory
tract of foals and a saprophyte thriving in the intestine of horses
and manure-containing farm soils. This dual lifestyle makes this
bacterium both a signiﬁcant burden to the thoroughbred industry
and an interesting model to study niche adaptation. Infection of
alveolar macrophages often leads to pyogranulomatous cavitating
pneumonia. Rhodococcus equi withstands phagocytosis by
diverting the phagolysosomal pathway into vacuoles permissive
for bacterial proliferation. Disruption of the phagolysosome
biogenesis depends on the presence of a pathogenicity island
(PAI) located within a conjugative plasmid. The PAI encodes a
family of six virulence associated proteins (Vap), which are
unique to Rhodococcus equi. Among them, VapA is the only cell
surface-located member of the family and, until recently, the only
PAI gene with a clearly identiﬁed role in virulence: arrest of
phagosomematuration [1]. Our recent work has shown two other
virulence-associated functions of the PAI: modulation of the
intracellular growth by IcgA [2] and co-option of the chromo-
somal gene expression by the PAI transcriptional regulators VirR
and VirS [3]. IcgA is a member of the major facilitator superfamily
transport proteins and its deletion resulted in a hypervirulent
phenotype. VirR and VirS regulate the expression of vapA and
other PAI genes in response to environmental cues associated
with the host environment. In addition, transcriptomic analysis
revealed that their regulatory effect spans over 20% of Rhodo-
coccus equi transcriptome, resulting in signiﬁcant changes of
transport processes, energy production and cellular metabolism.
In summary, the three known functions of the PAI are: i) VapA
creates an intracellular niche for Rhodococcus equi, ii) IcgA helps
maintaining the niche created by VapA and iii) the concerted
regulatory effect of VirR and VirS on the chromosomal gene
expression adjusts the bacterial physiology to suit the
requirements in the host environment. Interestingly, genomic
evidence strongly indicates that the PAI was acquired by the
avirulent ancestor of Rhodococcus equi in an event of lateral gene
transfer from a yet unknown donor [4] and most chromosomal
virulence-associated genes are conserved in non-pathogenic
Actinobacteria [5]. An example of the above is the recruitment of
the highly conserved biosynthetic genes for the siderophore
Rhequichelin for iron acquisition in the host environment [6].0737-0806/$ e see front matter.Taken together, these data indicate that the emergence of
virulence in a non-pathogenic ancestral bacterium was a gradual
process that was initiated by the acquisition of key adaptation
genes within the PAI, followed by alteration of chromosomal gene
expression patterns resulting in an adjustment of bacterial
physiology to suit the environment of the infected host.
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The incidence of macrolide and rifampin resistance in R. equi
isolated from foals has increased considerably in recent years. The
objective of this study was to identify the molecular mechanism
of emerging macrolide resistance in R. equi and to determine its
transferability. Macrolide-resistant (n¼62) and macrolide sus-
ceptible (n¼62) clinical isolates of R. equi from foals in the USA
were studied. Whole genome sequencing of a sample of 18
macrolide-resistant and 6 macrolide-susceptible R. equi was
performed. PCR was used to screen for the presence of the
resistance determinant in the other isolates. Mating experiments
were performed to document transfer of the determinant. A novel
erm gene, erm(46) was identiﬁed only in resistant isolates. There
was perfect association between macrolide resistance and
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S83eS87S84presence of erm(46) as detected by PCR in 124 isolates of R. equi.
Expression of erm(46) in a macrolide-susceptible strain of R. equi
induced high level resistance to macrolides, lincosamides, and
streptogramins B, but not to other classes of antimicrobial agents.
Transfer of erm(46) from resistant to susceptible strains of R. equi
was conﬁrmed and occurred at a transfer frequency of up to 2 
10-3. This is the ﬁrst molecular characterization of macrolide,
lincosamides and streptogramins B resistance in R. equi. Resis-
tance is caused by a novel erm gene, erm(46), which is trans-
ferrable likely by conjugation.
071
Chloroquine inhibits Rhodococcus equimultiplication in
murine (J774A.1) and foal alveolar macrophages
L.T. Gressler*1, A.I. Bordin 2, C.M. McQueen 2, A.C. de Vargas 1, N.D.
Cohen 2
1 Laboratory of Bacteriology, Department of Preventive Veterinary
Medicine, Federal University of Santa Maria, Santa Maria, RS
97105-900, Brazil; 2 Equine Infectious Disease Laboratory,
Department of Large Animal Clinical Sciences, College of
Veterinary Medicine, Texas A&M University, College Station, TX
77845, United States
Rhodococcus equi is a facultative intracellular pathogen that
primarily infects macrophages causing pyogranulomatous
pneumonia and many other extrapulmonary disorders in
young foals. The ability of R. equi to multiply in alveolar mac-
rophages (AMs) coupled with increasing prevalence of anti-
microbial resistance are the major obstacles for disease control.
There is a consensus that iron is a micronutrient essential for
all microorganisms; however, its availability also inﬂuences
intracellular replication and expression of virulence genes of R.
equi. Control of iron availability by host cells is a component of
nutritional immunity in vertebrates. Similarly, the drug chlo-
roquine (CQ), an aminoquinoline, has been used against
intracellular pathogens to limit iron availability inside phago-
cytic cells. Our hypothesis was that CQ would suppress the
growth of R. equi inside macrophages. We evaluated the R. equi
killing capacity of murine (J774A.1) and foal AMs exposed to
CQ (incubated 24 h prior to infection) with or without satu-
rated transferrin (HTF). CQ prevents the accumulation of iron
in cells, whereas HTF is a source of iron to R. equi, enhancing
the bacterium ability to survive and replicate intracellularly.
Thus, we investigated whether HTF would revert the inhibition
by CQ of intracellular survival of R. equi. We observed a sig-
niﬁcant (P < 0.05) inhibition of R. equi proliferation in both
murine J774A.1 and foal AMs exposed to 10 and 20 mM CQ for
24, 48, and 72 hours post-infection. HTF (6 mg/ml) did not
reverse CQ inhibition of R. equi intracellular survival, suggest-
ing that CQ impairs the iron uptake by R. equi cells via HTF, as
observed in other intracellular pathogens, such as Legionella
pneumophila and Paracoccidioides brasiliensis. We conclude that
CQ suppresses R. equi growth in both murine J77A.1 and foal
AMs. Further research is warranted to conﬁrm its purported
mechanism of iron-deprivation, as well as its therapeutic po-
tential against R. equi infection of foals in vivo.
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Oxidative stress (OS) is deﬁned as an imbalance between oxi-
dants and antioxidants. OS has been shown to play roles in
various equine respiratory diseases, speciﬁcally in association
with various inﬂammatory airway conditions. The role of OS
with respect to infectious respiratory diseases of horses has
been relatively poorly explored. The signiﬁcant of OS in the
pathogenesis Rhodococcus equi pneumonia in foals is unknown.
The object of these studies was to measure and relate respira-
tory and systemic biomarkers of OS to the pathology of R. equi
pneumonia and to the risk of developing this disease. An initial
case-control study compared various OS biomarkers from blood
and exhaled breath condensate (EBC) samples collected from 26
foals (n¼12, cases and n¼14, controls) residing on farms
endemically affected with the disease. Foals were deﬁned as
cases (positive) or controls (negative) based on ultrasono-
graphic evidence of pulmonary abscessation (>15 mm in
diameter). Haematology testing was also performed on bloods
collected. Comparison of biomarkers between the groups was
performed using two-sample t-tests. The following season a
prospective case-control study was performed on 74 foals
(n¼27, cases and n¼47 controls) in which systemic OS was
evaluated from blood samples collected within 24 hours of
birth and related to future diagnosis of R. equi pneumonia as
deﬁned in the previous study. The initial case-control study
showed reactive oxygen metabolites in blood (d-ROMs) to be
signiﬁcantly greater in case foals (P¼0.027) whilst the oxidative
stress index (OSI) was also highest in case foals (P¼0.014).
Hydrogen peroxide (H2O2) concentrations in EBC was also
signiﬁcantly greater in cases (P¼0.002). In the prospective
caseecontrol study, foals that developed disease had a signiﬁ-
cantly lower biological antioxidant potential in blood (P¼0.049)
within 24 hours of birth compared to those which didn’t
develop disease. These ﬁndings suggest that OS plays a role in
the pathogenesis of R. equi pneumonia and antioxidant capacity
may contribute to the innate risk of disease development in the
neonatal foal. These ﬁndings open up the potential use of OS
biomarker assays in the diagnosis of R. equi pneumonia and
potentially the identiﬁcation of ‘at risk’ foals at birth. These
results also open up the potential application of antioxidant
therapeutics to aid in the clinical management of foals with R.
equi pneumonia and as a non-antimicrobial prophylactic in
reducing risk of the neonatal foal developing disease.
